Table 3.
Polysomnographic, sleeping, and performance data.
| Control | Therapy | P-value | |||
|---|---|---|---|---|---|
| Baseline | 6 weeks | Baseline | 6 weeks | ||
| AHI | 20.1 (3.0) | 19.5 (3.5) | 20.8 (4.0) | 14.3 (4.1)†# | 0.004 |
| Minimum SaO2, % | 81.2 (3.3) | 82.2 (4.2) | 80.8 (4.6) | 85.8 (4.2)†# | 0.039 |
| AI | 17.3 (3.2) | 16.9 (3.8) | 18.2 (3.8) | 13.0 (3.3)†# | 0.010 |
| SI | 19.4 (4.4) | 18.2 (4.5) | 18.4 (4.4) | 13.7 (5.6)†# | 0.006 |
| SSS | 6.0 (5.0, 6.0) | 5.5 (5.0, 6.0) | 6.0 (5.0, 6.0) | 4.0 (3.0, 4.5)†# | 0.005 |
| PSQI | 8.0 (1.7) | 7.6 (1.8) | 7.6 (1.8) | 5.7 (1.9)†# | 0.017 |
| MMSE | 24.8 (2.5) | 26.1 (1.9)† | 25.8 (2.6) | 26.9 (2.2)† | 0.741 |
| FMA | 33.3 (8.2) | 42.0 (10.3)† | 30.5 (9.2) | 57.5 (15.2)†# | 0.006 |
| Barthel Index | 30.0 (27.5, 37.5) | 45.0 (35.0, 55.0)† | 30.0 (26.6, 35.0) | 60.0 (51.3, 70.0)†# | <0.001 |
AHI, apnea-hypopnea index; SaO2, oxygen saturation; AI, arousal index per sleep hour; SI, snore index; SSS, Stanford sleepiness scale; PSQI, Pittsburg sleep quality index scale; MMSE, Mini-mental State Examination; FMA, Fugl-Meyer Assessment. Values are presented as mean (standard deviation) or median (interquartile range).
†
P < 0.05 baseline vs. 6 weeks.
#
P < 0.05 control (6 weeks) vs. therapy (6 weeks).